| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 04/11/2007 | EP1771552A2 Influenza hemagglutinin and neuraminidase variants |
| 04/11/2007 | EP1771483A1 Anti-rhesus d recombinant polyclonal antibody and methods of manufacture |
| 04/11/2007 | EP1771482A2 Her2 antibody composition |
| 04/11/2007 | EP1771481A2 Novel anti-igf-ir antibodies and uses thereof |
| 04/11/2007 | EP1771480A1 Immunoglobulins comprising predominantly a man3glcnac2 glycoform |
| 04/11/2007 | EP1771479A1 IMMUNOGLOBULINS COMPRISING PREDOMINANTLY A GlCNACMAN5GLCNAC2 GLYCOFORM |
| 04/11/2007 | EP1771478A2 Immunoglobulins comprising predominantly a man5glcnac2 glycoform |
| 04/11/2007 | EP1771469A1 Use of llt1 and/or cd161 for modulating the activity of cells of the immune system |
| 04/11/2007 | EP1771205A2 Novel antigen-binding polypeptides and their uses |
| 04/11/2007 | EP1771202A2 Methods of modulating intracellular degradation rates of toxins |
| 04/11/2007 | EP1771193A1 Gus3 neuropeptides for regulating hypothalamic function |
| 04/11/2007 | EP1511768B1 Immunogenic compositions |
| 04/11/2007 | EP1175227B1 Monoclonal antibody directed against cells of human renal cell carcinoma |
| 04/11/2007 | EP1054894B1 Breast cancer resistance protein (bcrp) and the dna which encodes it |
| 04/11/2007 | EP1054683B1 Modified heat shock protein-antigenic peptide complex |
| 04/11/2007 | EP1021197B1 Implants comprising combinations of allogeneic cells for use in cancer treatment |
| 04/11/2007 | EP0988379B1 Ldl-receptor |
| 04/11/2007 | EP0961780B1 Protein markers for lung cancer and use thereof |
| 04/11/2007 | EP0741748B1 Monoclonal antibodies specific to vegf receptors and uses thereof |
| 04/11/2007 | EP0692031B1 Heterologous antigens in live cell vaccine strains |
| 04/11/2007 | CN1947012A Agonist anti-trkC antibodies and methods using same |
| 04/11/2007 | CN1946738A Animal product free system and process for purifying a botulinum toxin |
| 04/11/2007 | CN1946431A Compositions and methods for topical application and transdermal delivery of botulinum toxins |
| 04/11/2007 | CN1946425A Target for B-cell disorders |
| 04/11/2007 | CN1946424A Treatment of fungal infections |
| 04/11/2007 | CN1946423A Methods of diagnosing and treating pre-eclampsia or eclampsia |
| 04/11/2007 | CN1946422A Humanized antibodies against vascular endothelial growth factor |
| 04/11/2007 | CN1946421A Cancer treatment using viruses and camptothecins |
| 04/11/2007 | CN1946420A Immunising against meningococcal serogroup y using proteins |
| 04/11/2007 | CN1946417A Inhibitors of type 2 vascular endothelial growth factor receptors |
| 04/11/2007 | CN1946407A Methods and composition for treating tumors and metastatic disease |
| 04/11/2007 | CN1944652A Group B streptococcus antigens |
| 04/11/2007 | CN1944644A Process for preparing HIV-lgp120 and human gamma-interferon fusion protein |
| 04/11/2007 | CN1944462A Preparation of anti PV IgY antibody and its use in PV diagnostic reagent and preventing medicine |
| 04/11/2007 | CN1944460A Alr多肽及其应用 Alr peptide and its application |
| 04/11/2007 | CN1943784A New vaccine adjuvant |
| 04/11/2007 | CN1309836C Methods to culture circovirus |
| 04/11/2007 | CN1309738C Anti IL-8 monoclonal antibody, sequence of its variable region and application |
| 04/11/2007 | CN1309737C Recombinant gelatins |
| 04/11/2007 | CN1309734C Polypeptides involved in immune response |
| 04/11/2007 | CN1309733C Pepties from the 16/6id antibody for treating SLE |
| 04/11/2007 | CN1309420C Anticarious preparation of antibody |
| 04/11/2007 | CN1309419C A Blocking monoclonal antibody to VLA-1 and its use |
| 04/11/2007 | CN1309418C Immunostimulatory oligodeoxynucleotides |
| 04/11/2007 | CN1309417C Use of cell penetrating peptides to generate antitumor immunity |
| 04/11/2007 | CN1309392C Hyaluronic acid mediated adenoviral transduction |
| 04/10/2007 | US7202354 Hepatitis B virus surface antigen mutant and methods of detection thereof |
| 04/10/2007 | US7202351 Alteration of immune response using pan DR-binding peptides |
| 04/10/2007 | US7202343 Fully human monoclonal antibodies that inhibit neovascularization of solid tumors; assaying for MCP-1; cancer diagnosis; may be conjugated to a chemotherapeutic agent such as taxol, doxorubicin, cis-platinum, and 5-fluorouracil. |
| 04/10/2007 | US7202342 Compositions and methods for the therapy and diagnosis of prostate cancer |
| 04/10/2007 | US7202334 Compositions and methods for the therapy and diagnosis of ovarian cancer |
| 04/10/2007 | US7202331 For inducing immune response and administering immunotherapy |
| 04/10/2007 | US7202216 computer-assisted method for identifying potential modulators of Celiac Sprue and/or dermatitis herpetiformis, using a programmed computer |
| 04/10/2007 | US7202079 Evpression vector for use as tool in genetic engineering |
| 04/10/2007 | US7202071 Peptidyl t-RNA hydrolase (PTH) |
| 04/10/2007 | US7202045 Detection and treatment of cancers of the lung |
| 04/10/2007 | US7202034 Epitopes involved in the immune response to human papillomavirus; induction and/or enhancement of a T cell response directed towards an antigen, using peptides comprising specific epitopes for said antigen |
| 04/10/2007 | US7201912 Recombinant immunogenic compositions and methods for protecting against lethal infections from Bacillus anthracis |
| 04/10/2007 | US7201911 Cloned genomes of infectious hepatitis C viruses and uses thereof |
| 04/10/2007 | US7201910 Plasmids, expression vectors, diagnostic kits, and cells; fish vaccines |
| 04/10/2007 | US7201909 Genetic engineering; genome dsegment containing identifying phenotype; generation immunology response |
| 04/10/2007 | US7201908 Modified HPV E6 and E7 genes and proteins useful for vaccination |
| 04/10/2007 | US7201907 Attenuated human-bovine chimeric parainfluenza virus(PIV) vaccines |
| 04/10/2007 | US7201905 Fusion protein, comprising a receptor-antagonizing domain (such as prolactin receptor antagonist) and a positive immunomodulator domain (such as an interleukin); combines apoptosis induction and immunotherapy |
| 04/10/2007 | US7201904 Epitopes of hepatitis C virus |
| 04/10/2007 | US7201903 Method and device for detecting feline immunodeficiency virus |
| 04/10/2007 | US7201902 Production of recombinant protein pap 31 for the diagnosis and prevention of Bartonella bacilliformis infection |
| 04/10/2007 | US7201901 Capture, concentration and quantitation of abnormal prion protein from biological fluids using depth filtration |
| 04/10/2007 | US7201900 Comprises immunoglobulin for diagnosis, prognosis, detection and treatment of cancer; immunoassay; antitumor agents |
| 04/10/2007 | US7201898 Methods and compounds for controlled release of recombinant parvovirus vectors |
| 04/10/2007 | US7201890 Parenterally injecting patient with labeled divalent single chain antibody fragment or subfragment; conducting procedure within 48 hours of the injection; scanning the accessed interior locating sites of accretion of labeled antibody |
| 04/10/2007 | US7201730 Device and method for reducing inflammatory mediators in blood |
| 04/10/2007 | CA2389896C Use of treosulfan for patient conditioning before bone marrow or blood stem cell transplantation |
| 04/10/2007 | CA2302554C Oil in water emulsions containing saponins |
| 04/10/2007 | CA2278684C Thimerosal-free preservatives for vaccines |
| 04/10/2007 | CA2254931C Human monoclonal antibodies to the hepatitis b surface antigen |
| 04/10/2007 | CA2209172C Murine monoclonal anti-idiotype antibody 3h1 |
| 04/10/2007 | CA2171289C Il8 inhibitors |
| 04/10/2007 | CA2168671C A method for high loading of vesicles with biopolymeric substances |
| 04/10/2007 | CA2154023C Recombinant infectious non-segmented negative strand rna virus |
| 04/10/2007 | CA2150816C Monoclonal antibodies directed against the microtubule- associated protein tau, hybridomas secreting these antibodies, antigen recognition by these monoclonal antibodies and theirapplications |
| 04/10/2007 | CA2125174C Novel polypeptides for promoting cell attachment |
| 04/10/2007 | CA2071016C Method for detecting bovine diarrhoea virus infection nucleotide sequence encoding a protein induced by this virus infection and recombinant proteins and antigens relating thereto |
| 04/05/2007 | WO2007038453A2 Use of an anti-vascular endothelial growth factor (vegf) agent to ameliorate inflammation |
| 04/05/2007 | WO2007038331A2 Novel chemical compounds |
| 04/05/2007 | WO2007038316A2 Human cytomegalovirus latency promoting genes, related virus variants and methods of use |
| 04/05/2007 | WO2007038282A2 Stabilization of clostridium botulinum neurotoxin complex |
| 04/05/2007 | WO2007038249A2 Ultrasonic concentration of carrier particles |
| 04/05/2007 | WO2007038246A2 Solid polymer delivery compositions and methods for use thereof |
| 04/05/2007 | WO2007038122A2 Immunogenic capsule composition for use as a vaccine component against campylobacter jejuni |
| 04/05/2007 | WO2007038083A2 Heat shock proteins from mycobacterium leprae and uses thereof |
| 04/05/2007 | WO2007037788A1 Antibody composition and passive immunization against pregnancy-induced hypertension using antidigoxin antibody (digibind) |
| 04/05/2007 | WO2007037782A2 Method for treating prostate conditions |
| 04/05/2007 | WO2007037669A2 Compositions for prevention and treatment of infections caused by eimeria parasites in animals |
| 04/05/2007 | WO2007037560A1 Therapeutic or diagnostic application of sgk2 gene |
| 04/05/2007 | WO2007037555A1 Therapeutic or diagnostic application of dusp15 gene |
| 04/05/2007 | WO2007037550A1 Therapeutic or diagnostic application of tsta3 gene |
| 04/05/2007 | WO2007037538A1 Therapeutic or diagnostic application of spo11 gene |
| 04/05/2007 | WO2007037533A1 Therapeutic or diagnostic application of ppp1r3d gene |
| 04/05/2007 | WO2007037532A1 Therapeutic or diagnostic application of srms gene |